Skip to content
Home/Companies/Biotech/Curasight A/S

Curasight A/S

Biotech·Denmark·Exited 2020·Held 6yr
Entry
2014
Hold
6yr
Exit
2020

Who owns Curasight A/S?

Curasight A/S was owned by PreSeed Ventures through PreSeed Ventures (early) (2000 vintage) from 2014 to 2020, exited via IPO.

Hand-verified · updated 2026-08-18

PreSeed Ventures
Investor
PreSeed Ventures
PreSeed Ventures (early) · 2000 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2020

More from PreSeed Ventures (early)

Other portfolio companies in the same fund.

GoMore
Exited 2022
MobilityDenmark· 2014
to
Penneo
Exited 2020
LegalTechDenmark· 2014
MinervaX
MinervaX
Active
BiotechDenmark· 2010
Trustpilot
Exited 2021
TMTDenmark· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Curasight A/S

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Curasight A/S?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Curasight A/S.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue